The selective norepinephrine reuptake inhibitor, LY368975, reduces food consumption in animal models of feeding

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 1, 1998, Pages 122-127

  Gehlert, Donald R ^a   Dreshfield, Laura ^a   Tinsley, Frank ^a   Benvenga, Mark J ^a   Gleason, Scott ^a   Fuller, Ray W ^a   Wong, David T ^a   Hemrick Luecke, Susan K ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN UPTAKE INHIBITOR; THIONISOXETINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; FEEDING DISORDER; FOOD INTAKE; MALE; MOUSE; NONHUMAN; NORADRENALIN BRAIN LEVEL; NORADRENALIN RELEASE; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; CARRIER PROTEINS; EATING; FLUOXETINE; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; OXIDOPAMINE; PAROXETINE; PROPYLAMINES; RATS; RATS, SPRAGUE-DAWLEY; SYMPORTERS;

EID: 0032462875     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Fuller RW (1982) Pharmacology of brain epinephrine neurons. Ann Rev Pharmacol Toxicol 22:31-55.
2. Fuller RW and Hemrick-Luecke SK (1983) Antagonism by tomoxetine of the depletion of norepinephrine and epinephrine in rat brain by α-methyl-m-tyrosine. Res Commun Chem Pathol Pharmacol 41:169-172.
3. Fuller RW, Hemrick-Luecke SK and Snoddy HD (1994) Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice. J Pharmacol Exp Ther 269:132-136.
4. Fuller RW and Perry KW (1977) Lowering of epinephrine concentration in rat brain by 2,3-dichloro-α-methyl-benzylamine, an inhibitor of norepinephrine-N-methyl-transferase. Biochem Pharmacol 26:2087-2090.
5. Fuller RW and Perry KW (1989) Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites. J Pharmacol Exp Ther 248:50-56.
6. Fuller RW, Perry KW and Molloy BB (1974) Effect of an uptake inhibitor on serotonin metabolism in rat brain: studies with 3(p-trifluoromethylphenoxy)-N-methyl-3-phenylproylamine (Lilly 110140). Life Sci 15:1161-1171.
7. Gehlert DR, Hemrick-Luecke SK, Schober DA, Krushinski J, Howbert JJ, Robertson DW, Wong DT and Fuller RW (1995) (R)-Thionisoxetine, a potent and selective inhibitor of central and peripheral norepinephrine uptake. Life Sci 56:1915-1920.
8. Grossman SP (1960) Eating or drinking elicited by adrenergic or cholinergic stimulation of hypothalamus. Science 132:301-302.
9. Jackson HC, Needham AM, Hutchins LJ, Mazurkiewicz SE and Heal DJ (1997) Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat. Br J Pharmacol 121:1758-1762.
10. Leibowitz SF (1988) Hypothalamic paraventricular nucleus: interactions between alpha 2-noradrenergic system and circulating hormones and nutrients in relation to energy balance. Neurosci Biobehav Rev 8:101-109.
11. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
12. Tessel RE, Kennedy LE, Burgess SK and Borchardt RT (1978) Epinephrine in rat hypothalamus: antagonism by desipramine of 6-hydroxydopamine induced depletion. Brain Res 153:615-617.
13. Trendelenburg U (1988) The extraneuronal uptake and metabolism of catecholamines, in Handbook of Experimental Pharmacology (Trendelenburg U and Weiner N, eds) pp 279-319, Springer, Berlin.
14. Wellman PJ and Davies BT (1991) Reversal of phenylpropanolamine anoxexia in rats by the alpha-1 receptor antagonist benoxathian. Pharmacol Biochem Behav 38:905-908.
15. Wong DT and Bymaster FP (1976) Effect of nisoxetine on uptake of catecholamines in synaptosomes isolated from discrete regions of rat brain. Biochem Pharmacol 25:1979-1983.
16. Wong DT, Bymaster FP, Mayle DA, Reid LR, Krushinski JH and Robertson DW (1993) LY248686, a new inhibitor of serotonin and norepinephrine uptake. Neuropsychopharmacology 8:23-33.
17. Wong DT, Horng JS and Bymaster FP (1975) dl-N-methyl-3-(p-methoxyphenoxy)-3-phenylpropylame hydrochloride, Lilly 94939, a potent inhibitor for uptake of norepinephrine into rat brain synaptosomes and heart. Life Sci 17:755-760.
18. Wong DT, Threlkeld PG, Best KL and Bymaster FP (1982) A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain. J Pharmacol Exp Ther 222:61-65.